Amgen (Nasdaq: AMGN) and Arrowhead Pharmaceuticals Inc. (Nasdaq: ARWR) announced two license and collaboration agreements to develop and commercialize RNA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE